Relevant bibliographies by topics / General Unknown Screening

Contents

  1. Journal articles

Academic literature on the topic 'General Unknown Screening'

Author: Grafiati
Published: 11 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'General Unknown Screening.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "General Unknown Screening"

1

Böhme. "Improved “General Unknown” Drug Screening Using GCxGCqMS." Scientia Pharmaceutica 77, no. 1 (2009): 183. http://dx.doi.org/10.3797/scipharm.oephg.21.sl-16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Lowres, Nicole, Lis Neubeck, Julie Redfern, and S. Ben Freedman. "Screening to identify unknown atrial fibrillation." Thrombosis and Haemostasis 110, no. 08 (2013): 213–22. http://dx.doi.org/10.1160/th13-02-0165.

Full text
Abstract:
SummaryAtrial fibrillation (AF) is associated with a significantly increased stroke risk which is highly preventable with appropriate oral anticoagulant therapy (OAC). However, AF may be asymptomatic and unrecognised prior to stroke. We aimed to determine if single time-point screening for AF could identify sufficient numbers with previously undiagnosed AF, to be effective for stroke prevention. This is a systematic review of clinical trials, by searching electronic medical databases, reference lists and grey literature. Studies were included if they evaluated a general ambulant adult population, using electrocardiography or pulse palpation to identify AF. We identified 30 individual studies (n=122,571, mean age 64 years, 54% male) in nine countries. Participants were recruited either from general practitioner and outpatient clinics (12 studies) or population screening/community advertisements (18 studies). Prevalence of AF across all studies was 2.3% (95% CI, 2.2–2.4%), increasing to 4.4% (CI, 4.1–4.6%) in those ≥65 years (16 studies, n= 27,884). Overall incidence of previously unknown AF (14 studies, n=67,772) was 1.0% (CI, 0.89–1.04%), increasing to 1.4% (CI, 1.2–1.6%) in those ≥65 years (8 studies, n= 18,189) in whom screening setting did not influence incidence identified. Of those with previously unknown AF, 67% were at high risk of stroke. Screening can identify 1.4% of the population ≥65 years with previously undiagnosed AF. Many of those identified would be eligible for, and benefit from OAC to prevent stroke. Given this incidence, community AF screening strategies in at risk older age groups could potentially reduce the overall health burden associated with AF.
APA, Harvard, Vancouver, ISO, and other styles
3

Richeval, C., J. F. Wiart, L. Humbert, M. Shbair, and M. Lhermitte. "General unknown screening of xenobiotics: the contribution of an acidic extraction." Annales de Toxicologie Analytique 23, no. 3 (2011): 119–24. http://dx.doi.org/10.1051/ata/2011120.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Sukumaran, NimishaPulikkal, and RHiranmai Yadav. "General unknown screening, antioxidant and anti-inflammatory potential of Dendrobium macrostachyum Lindl." Ancient Science of Life 35, no. 4 (2016): 240. http://dx.doi.org/10.4103/0257-7941.188181.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Duretz, B., S. Robinson, S. Scurati, E. Genin, and D. Lamiable. "General unknown screening of illicit drugs: A novel approach using high resolution and accurate mass." Toxicology Letters 196 (July 2010): S291—S292. http://dx.doi.org/10.1016/j.toxlet.2010.03.920.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Marquet, P., N. Venisse, É. Lacassie, and G. Lachâtre. "In-source CID mass spectral libraries for the “general unknown” screening of drugs and toxicants." Analusis 28, no. 10 (2000): 925–34. http://dx.doi.org/10.1051/analusis:2000280925.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Köppel, C., and J. Tenczer. "Scope and limitations of a general unknown screening by gas chromatography—mass spectrometry in acute poisoning." Journal of the American Society for Mass Spectrometry 6, no. 11 (1995): 995–1003. http://dx.doi.org/10.1016/1044-0305(95)00585-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Sauvage, François-Ludovic, Nicolas Picard, Franck Saint-Marcoux, Jean-Michel Gaulier, Gérard Lachâtre, and Pierre Marquet. "General unknown screening procedure for the characterization of human drug metabolites in forensic toxicology: Applications and constraints." Journal of Separation Science 32, no. 18 (2009): 3074–83. http://dx.doi.org/10.1002/jssc.200900092.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Picard, Nicolas, Dorra Dridi, François-Ludovic Sauvage, Naceur A. Boughattas, and Pierre Marquet. "General unknown screening procedure for the characterization of human drug metabolites: Application to loratadine phase I metabolism." Journal of Separation Science 32, no. 13 (2009): 2209–17. http://dx.doi.org/10.1002/jssc.200900099.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Tos, Tina, Helle Klyver, and Krzysztof T. Drzewiecki. "Extensive screening for primary tumor is redundant in melanoma of unknown primary." Journal of Surgical Oncology 104, no. 7 (2011): 724–27. http://dx.doi.org/10.1002/jso.21994.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources
You might also be interested in the extended bibliographies on the topic 'General Unknown Screening' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography